Business Description
PT Indofarma Tbk
ISIN : ID1000068406
Share Class Description:
ISX:INAF: Class BTotal Employee Number:
51Compare
Compare
Traded in other countries / regions
INAF.Indonesia IPO Date
2001-04-17Description
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others. The Medicine business segment includes drug production, marketing distribution, and sales. The Medical Device Segment includes medical devices and other products. Company generates majority revenue from the Medicine segment. The Company classifies its distribution segments based on geographic regions into six areas, namely Java, Sumatra, Kalimantan, Sulawesi, Bali dan West Nusa Tenggara (NTB),as well as the Eastern Indonesia region.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -1.32 | |||||
Debt-to-Equity | -0.99 | |||||
Debt-to-EBITDA | -17.55 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -4.68 | |||||
Beneish M-Score | -0.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -46.3 | |||||
3-Year EBITDA Growth Rate | 56.7 | |||||
3-Year EPS without NRI Growth Rate | 14.7 | |||||
3-Year FCF Growth Rate | -32.9 | |||||
3-Year Book Growth Rate | -382 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.19 | |||||
Quick Ratio | 0.08 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 110.2 | |||||
Days Sales Outstanding | 91.2 | |||||
Days Payable | 583.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 8.04 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -12.68 | |||||
Operating Margin % | -137.39 | |||||
Net Margin % | -51.46 | |||||
EBITDA Margin % | -26.33 | |||||
FCF Margin % | -110.05 | |||||
OCF Margin % | -110.05 | |||||
ROA % | -13.59 | |||||
ROIC % | -20.49 | |||||
3-Year ROIIC % | -48.62 | |||||
ROC (Joel Greenblatt) % | -11.88 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.58 | |||||
EV-to-EBIT | -27.27 | |||||
EV-to-EBITDA | -28.03 | |||||
EV-to-Revenue | 7.38 | |||||
EV-to-FCF | -5.33 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Median-PS-Value | 0.98 | |||||
Earnings Yield (Greenblatt) % | -3.67 | |||||
FCF Yield % | -53.77 | |||||
Forward Rate of Return (Yacktman) % | 13.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PT Indofarma Tbk Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil Rp) | 168,113.842 | ||
| EPS (TTM) (Rp) | -19.518 | ||
| Beta | -0.0955 | ||
| 3-Year Sharpe Ratio | -0.61 | ||
| 3-Year Sortino Ratio | -0.76 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (Rp) | - | ||
| 20-Day SMA (Rp) | 126 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (Rp) | 126 - 126 | ||
| Shares Outstanding (Mil) | 3,099.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PT Indofarma Tbk Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PT Indofarma Tbk Stock Events
| Event | Date | Price (Rp) | ||
|---|---|---|---|---|
| No Event Data | ||||
PT Indofarma Tbk Frequently Asked Questions
What is PT Indofarma Tbk(ISX:INAF)'s stock price today?
The current price of ISX:INAF is Rp126.00. The 52 week high of ISX:INAF is Rp126.00 and 52 week low is Rp126.00.
When is next earnings date of PT Indofarma Tbk(ISX:INAF)?
The next earnings date of PT Indofarma Tbk(ISX:INAF) is .
Does PT Indofarma Tbk(ISX:INAF) pay dividends? If so, how much?
PT Indofarma Tbk(ISX:INAF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on PT Indofarma Tbk
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers